Surmodics | Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 24.84B 371M 2025-09
Align Technology USD 2.62B 82.47M 2025-12
Anika Therapeutics USD 101.59M 2.27M 2025-09
Arrowhead Research USD 1.17B 223.75M 2025-12
Baxter International USD 6.93B 184M 2025-09
Boston Scientific USD 8.04B 914M 2025-09
EDAP TMS EUR 51.48M 6.99M 2025-06
Edwards Lifesciences USD 6.36B 218.3M 2025-09
Haemonetics USD 943.67M 43.99M 2025-12
Heron Therapeutics USD 229.4M 18.48M 2025-09
J&J USD 54.61B 113M 2025-09
Merit Medical Systems USD 985.53M 62.46M 2025-09
Mesa Laboratories USD 105.63M 8.2M 2025-12
Nektar Therapeutics USD 281.36M 94.79M 2025-09
Option Care Health USD 1.28B 107.54M 2025-09
Stryker USD 14.76B 1.04B 2025-12
Surmodics USD 81.3M 948K 2024-09
Trinity Biotech USD 35.52M 2.52M 2025-09


Surmodics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.